Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Steven Nwe"'
Autor:
Cristina Thomas, Saravu R Narahari, Kuthaje S Bose, Kuthaje Vivekananda, Steven Nwe, Dennis P West, Mary Kwasny, Roopal V Kundu
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 2, p e2716 (2014)
BACKGROUND: The Global Program to Eliminate Lymphatic Filariasis aims to interrupt transmission of lymphatic filariasis and manage morbidity in people currently living with the disease. A component of morbidity management is improving health-related
Externí odkaz:
https://doaj.org/article/4a6e82c9ddbe48d19557b97b74996f17
Publikováno v:
The American Journal of Dermatopathology. 42:547-547
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368b8d76709a8d56f68b85b29afa01ae
https://doi.org/10.1097/dad.0000000000001417
https://doi.org/10.1097/dad.0000000000001417
Publikováno v:
The American Journal of Dermatopathology. 42:e102-e102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302ad58e46045c7d34e90a6f2f37d725
https://doi.org/10.1097/dad.0000000000001416
https://doi.org/10.1097/dad.0000000000001416
Autor:
Laura K. Bianchi, Benjamin Witt, Steven Nwe, Curtis Hall, Hongyan Du, Bhupesh Pokhrel, Eugene F. Yen
Publikováno v:
Inflammatory Bowel Diseases. 18:1835-1841
Background: Cigarette smoking is an important environmental factor affecting inflammatory bowel disease. The role of smoking has not been rigorously studied in microscopic colitis (MC). The aim of this study was to compare the association of cigarett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acbf9c114ec817573fcb7eca510d18ed
https://doi.org/10.1002/ibd.22838
https://doi.org/10.1002/ibd.22838
Autor:
Anshika, Kaushik, Anne, Laumann, Steven, Nwe, Mary J, Kwasny, Dennis P, West, Roopal V, Kundu
Publikováno v:
Journal of drugs in dermatology : JDD. 14(4)
Photosensitivity (PS) in cutaneous lupus erythematosus (CLE) contributes to decreased quality of life (QoL).We aimed to assess baseline knowledge about sun protection in persons with CLE and identify knowledge differences by race. Additionally, we ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa2781405a95525f9afa7f8a2cf44427
https://pubmed.ncbi.nlm.nih.gov/25844608
https://pubmed.ncbi.nlm.nih.gov/25844608
Autor:
Steven Nwe, Kenneth B. Gordon
Publikováno v:
Psoriasis: Diagnosis and Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::509e5460422f36c1a05dafa0c0c3d6b9
https://doi.org/10.1002/9781118661796.ch15
https://doi.org/10.1002/9781118661796.ch15
Comparison of three quality of life instruments in lymphatic filariasis: DLQI, WHODAS 2.0, and LFSQQ
Autor:
Dennis P. West, Saravu R. Narahari, Roopal V. Kundu, Steven Nwe, Kuthaje Vivekananda, Cristina Thomas, Mary J. Kwasny, Kuthaje S. Bose
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 2, p e2716 (2014)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background The Global Program to Eliminate Lymphatic Filariasis aims to interrupt transmission of lymphatic filariasis and manage morbidity in people currently living with the disease. A component of morbidity management is improving health-related q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd584df2bdbf440f0127bcfe2afc698
http://europepmc.org/articles/PMC3930502?pdf=render
http://europepmc.org/articles/PMC3930502?pdf=render
Publikováno v:
Expert review of clinical immunology. 9(7)
Psoriasis vulgaris is a chronic, immune-mediated, inflammatory disease that affects between 2 and 3% of the US population. Often severely physically and emotionally debilitating, psoriasis has driven investigators to strive to better characterize its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b182c272541e2e3b23d451707f947648
https://pubmed.ncbi.nlm.nih.gov/23899238
https://pubmed.ncbi.nlm.nih.gov/23899238
Publikováno v:
The British Journal of Dermatology
Background Tofacitinib (CP-690,550) is a novel Janus kinase inhibitor in development as an oral formulation for the treatment of several inflammatory diseases including psoriasis. Objectives This phase 2a study aimed to assess the efficacy, systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fb75385fcac7f5f387fcac709ebdb1
https://doi.org/10.1111/bjd.12434
https://doi.org/10.1111/bjd.12434
Publikováno v:
American Journal of Gastroenterology. 104:S57-S58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0697b57c8da4773504c9eead1c2c249d
https://doi.org/10.14309/00000434-200910003-00145
https://doi.org/10.14309/00000434-200910003-00145